Isradipina un nuevo calcio antagonista en la angina de pecho estable

Hernández Hernández, R; Rodríguez de Salazar, M. C; Armas de Hernández, Maria José; Armas Padilla, Maria Cristina; Machado de Alvarado, I.
Arch. venez. farmacol. ter ; 8(1): 56-61, 1989. ilus
Artículo en Español | LILACS | ID: lil-79094

Documentos relacionados

  1. Usefulness of Angina to Guide Revascularization Decisions.
  2. Rare Cause of Exertional Angina.
  3. Optimal Medical Therapy as First-Line Therapy for Chronic Coronary Syndromes: Lessons from COURAGE, BARI 2D, FAME 2, and ISCHEMIA.
  4. The Efficacy of Danshen Injection as Adjunctive Therapy in Treating Angina Pectoris: A Systematic Review and Meta-Analysis.
  5. Microvascular cardiac amyloidosis-Cardiac involvement of amyloidosis presenting as typical chest pain.
  6. Mechanisms and diagnostic evaluation of persistent or recurrent angina following percutaneous coronary revascularization.
  7. Consensus Statement on Holistic Management of Angina.
  8. The sham effect of invasive interventions in chronic coronary syndromes: a systematic review and meta-analysis.
  9. Uric Acid Level Has a U-shaped Association with Clinical Outcomes in Patients with Vasospastic Angina.
  10. [Overview of systematic reviews on Shuxuening Injection].